ASX - By Stock
|
NEU |
Re:
M&A
|
|
mayfair
|
249 |
138K |
2 |
19/05/25 |
19/05/25 |
ASX - By Stock
|
249
|
138K
|
2
|
|
ASX - By Stock
|
NEU |
Re:
6 New Indications
|
|
mayfair
|
18 |
9.3K |
13 |
01/03/25 |
01/03/25 |
ASX - By Stock
|
18
|
9.3K
|
13
|
|
ASX - By Stock
|
NEU |
Re:
6 New Indications
|
|
mayfair
|
18 |
9.3K |
14 |
01/03/25 |
01/03/25 |
ASX - By Stock
|
18
|
9.3K
|
14
|
|
ASX - By Stock
|
NEU |
Re:
Ann: 2024 Full Year Results webinar
|
|
mayfair
|
72 |
27K |
1 |
01/03/25 |
01/03/25 |
ASX - By Stock
|
72
|
27K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Ann: DAYBUE (trofinetide) 2024 net sales US$348 million
|
|
mayfair
|
34 |
17K |
2 |
27/02/25 |
27/02/25 |
ASX - By Stock
|
34
|
17K
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
mayfair
|
1.6K |
833K |
0 |
26/02/25 |
26/02/25 |
ASX - By Stock
|
1.6K
|
833K
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Fast Track granted by FDA for NNZ-2591 in Pitt Hopkins
|
|
mayfair
|
41 |
22K |
3 |
20/02/25 |
20/02/25 |
ASX - By Stock
|
41
|
22K
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
mayfair
|
1.6K |
833K |
9 |
10/02/25 |
10/02/25 |
ASX - By Stock
|
1.6K
|
833K
|
9
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
mayfair
|
1.6K |
833K |
4 |
09/02/25 |
09/02/25 |
ASX - By Stock
|
1.6K
|
833K
|
4
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
mayfair
|
16K |
8.1M |
0 |
10/01/25 |
10/01/25 |
ASX - By Stock
|
16K
|
8.1M
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Ann: DAYBUE receives marketing authorization in Canada
|
|
mayfair
|
42 |
24K |
5 |
28/11/24 |
28/11/24 |
ASX - By Stock
|
42
|
24K
|
5
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Neuren announces A$50m on-market share buy-back program
|
|
mayfair
|
152 |
79K |
5 |
26/11/24 |
26/11/24 |
ASX - By Stock
|
152
|
79K
|
5
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Neuren announces A$50m on-market share buy-back program
|
|
mayfair
|
152 |
79K |
12 |
24/11/24 |
24/11/24 |
ASX - By Stock
|
152
|
79K
|
12
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
mayfair
|
1.6K |
833K |
1 |
06/11/24 |
06/11/24 |
ASX - By Stock
|
1.6K
|
833K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
mayfair
|
16K |
8.1M |
6 |
30/08/24 |
30/08/24 |
ASX - By Stock
|
16K
|
8.1M
|
6
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
mayfair
|
16K |
8.1M |
8 |
17/07/24 |
17/07/24 |
ASX - By Stock
|
16K
|
8.1M
|
8
|
|
ASX - By Stock
|
NEU |
Re:
Pipeline-in-a-drug
|
|
mayfair
|
230 |
121K |
7 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
230
|
121K
|
7
|
|
ASX - By Stock
|
NEU |
Re:
Pipeline-in-a-drug
|
|
mayfair
|
230 |
121K |
2 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
230
|
121K
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Pipeline-in-a-drug
|
|
mayfair
|
230 |
121K |
6 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
230
|
121K
|
6
|
|
ASX - By Stock
|
NEU Tax & Taxation |
Re:
Capital gains tax
|
|
mayfair
|
24 |
26K |
3 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
24
|
26K
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
mayfair
|
1.8K |
1.0M |
1 |
02/06/24 |
02/06/24 |
ASX - By Stock
|
1.8K
|
1.0M
|
1
|
|
ASX - By Stock
|
NEU Tax & Taxation |
Re:
Capital gains tax
|
|
mayfair
|
24 |
26K |
0 |
02/06/24 |
02/06/24 |
ASX - By Stock
|
24
|
26K
|
0
|
|
ASX - By Stock
|
NEU Tax & Taxation |
Re:
Capital gains tax
|
|
mayfair
|
24 |
26K |
2 |
02/06/24 |
02/06/24 |
ASX - By Stock
|
24
|
26K
|
2
|
|
ASX - By Stock
|
NEU Tax & Taxation |
Re:
Capital gains tax
|
|
mayfair
|
24 |
26K |
1 |
01/06/24 |
01/06/24 |
ASX - By Stock
|
24
|
26K
|
1
|
|
ASX - By Stock
|
NEU Tax & Taxation |
Re:
Capital gains tax
|
|
mayfair
|
24 |
26K |
3 |
01/06/24 |
01/06/24 |
ASX - By Stock
|
24
|
26K
|
3
|
|
ASX - By Stock
|
NEU Tax & Taxation |
Re:
Capital gains tax
|
|
mayfair
|
24 |
26K |
4 |
01/06/24 |
01/06/24 |
ASX - By Stock
|
24
|
26K
|
4
|
|
ASX - By Stock
|
NEU Tax & Taxation |
Capital gains tax
|
|
mayfair
|
24 |
26K |
3 |
01/06/24 |
01/06/24 |
ASX - By Stock
|
24
|
26K
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
mayfair
|
16K |
8.1M |
2 |
01/06/24 |
01/06/24 |
ASX - By Stock
|
16K
|
8.1M
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
mayfair
|
16K |
8.1M |
2 |
01/06/24 |
01/06/24 |
ASX - By Stock
|
16K
|
8.1M
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Trading Halt
|
|
mayfair
|
231 |
140K |
2 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
231
|
140K
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Neuren - where to from here ?
|
|
mayfair
|
100 |
72K |
23 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
100
|
72K
|
23
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
mayfair
|
16K |
8.1M |
8 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
16K
|
8.1M
|
8
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
mayfair
|
16K |
8.1M |
11 |
24/12/23 |
24/12/23 |
ASX - By Stock
|
16K
|
8.1M
|
11
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
mayfair
|
1.8K |
1.0M |
27 |
20/12/23 |
20/12/23 |
ASX - By Stock
|
1.8K
|
1.0M
|
27
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Trading Halt
|
|
mayfair
|
315 |
175K |
6 |
16/12/23 |
16/12/23 |
ASX - By Stock
|
315
|
175K
|
6
|
|
ASX - By Stock
|
NEU |
Re:
Merck to acquire Prometheus in a US$ 10.8 b deal
|
|
mayfair
|
108 |
71K |
4 |
11/12/23 |
11/12/23 |
ASX - By Stock
|
108
|
71K
|
4
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
mayfair
|
16K |
8.1M |
4 |
29/11/23 |
29/11/23 |
ASX - By Stock
|
16K
|
8.1M
|
4
|
|
ASX - By Stock
|
EYE |
Re:
Ann: Notice Of Annual General Meeting
|
|
mayfair
|
12 |
3.3K |
0 |
24/10/23 |
24/10/23 |
ASX - By Stock
|
12
|
3.3K
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
mayfair
|
16K |
8.1M |
3 |
17/10/23 |
17/10/23 |
ASX - By Stock
|
16K
|
8.1M
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
mayfair
|
16K |
8.1M |
22 |
09/10/23 |
09/10/23 |
ASX - By Stock
|
16K
|
8.1M
|
22
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
mayfair
|
16K |
8.1M |
6 |
04/09/23 |
04/09/23 |
ASX - By Stock
|
16K
|
8.1M
|
6
|
|
ASX - By Stock
|
EYE |
Re:
Nova Eye Medical (EYE) Discussion
|
|
mayfair
|
3.2K |
959K |
1 |
04/09/23 |
04/09/23 |
ASX - By Stock
|
3.2K
|
959K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
mayfair
|
16K |
8.1M |
8 |
06/08/23 |
06/08/23 |
ASX - By Stock
|
16K
|
8.1M
|
8
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
mayfair
|
16K |
8.1M |
12 |
05/08/23 |
05/08/23 |
ASX - By Stock
|
16K
|
8.1M
|
12
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
mayfair
|
1.8K |
1.0M |
39 |
30/07/23 |
30/07/23 |
ASX - By Stock
|
1.8K
|
1.0M
|
39
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
mayfair
|
1.8K |
1.0M |
10 |
29/07/23 |
29/07/23 |
ASX - By Stock
|
1.8K
|
1.0M
|
10
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
mayfair
|
16K |
8.1M |
9 |
28/07/23 |
28/07/23 |
ASX - By Stock
|
16K
|
8.1M
|
9
|
|
ASX - By Stock
|
EYE |
Re:
Fundies Loading Up
|
|
mayfair
|
19 |
7.1K |
1 |
26/07/23 |
26/07/23 |
ASX - By Stock
|
19
|
7.1K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
mayfair
|
16K |
8.1M |
13 |
21/07/23 |
21/07/23 |
ASX - By Stock
|
16K
|
8.1M
|
13
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
mayfair
|
16K |
8.1M |
4 |
21/07/23 |
21/07/23 |
ASX - By Stock
|
16K
|
8.1M
|
4
|
|